ES2055792T3 - Compuestos analogos ciclicos a grf. - Google Patents

Compuestos analogos ciclicos a grf.

Info

Publication number
ES2055792T3
ES2055792T3 ES89307089T ES89307089T ES2055792T3 ES 2055792 T3 ES2055792 T3 ES 2055792T3 ES 89307089 T ES89307089 T ES 89307089T ES 89307089 T ES89307089 T ES 89307089T ES 2055792 T3 ES2055792 T3 ES 2055792T3
Authority
ES
Spain
Prior art keywords
ala
arg
leu
gln
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89307089T
Other languages
English (en)
Inventor
Jean Edouard Frederic Rivier
Wylie Walker Vale Jr
Catherine Laure Rivier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Application granted granted Critical
Publication of ES2055792T3 publication Critical patent/ES2055792T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Amplifiers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Control Of El Displays (AREA)

Abstract

PEPTIDOS SINTETICOS QUE ESTIMULAN LA LIBERACION DE PITUITARIA GH EN ANIMALES, INCLUYENDO HUMANOS, Y SON MAS RESISTENTES A LA DEGRADACION ENZIMATICA EN EL CUERPO QUE HGRF, QUE TIENEN LA SECUENCIA: (B)R1-R1-R2-R3 ALA - ILE - PHE - THR - R8 - SER - (VACIO)10 - ARG - R12-R13 - LEU - R15 - GLN LEU - R18 - ALA - ARG - R21-R22 - LEU - R24-R25 - ILE - R27-R28-R29 - GLN GLN - GLU - R34 - ASN - GLN - GLU - R38-R39-R40 - ARG - R42-R43-R44, DONDE R1 ES TYR, D-TYR, MET, D-MET, PHE, D-PHE, PCL-PHE, LEU, HIS O D-HIS; B ES H, CAME, NAME, DESAMINO, AC O FOR; R2 ES ALA, D-ALA, NMA O D-NMA; R3 ES ASP O D-ASP; R8 ES SER, ASN, LYS, ARG, ASP O GLN; R10 ES TYR, D-TYR O PHE; R12 ES ARG O LYS; R13 ES ILE, VAL, LEU O ALA; R15 ES GLY, ALA O (BETA)-ALA; R18 ES SER O TYR; R21 ES LYS, D-LYS, ARG O D-ARG; R22 ES LEU, ILE, ALA O VAL; R24 ES GLN O HIS; R25 ES CYS, ABU, ASP, GLU, ORN, LYS, DAR O DAP; R27 ES MET, D-MET, ALA, NLE, ILE, NEU NVA O VAL; R28 ES ASN O SER; R29 ES CYS, ABU, ASP, GLU, ORN, LYS, DAB O DAP; R31 ES SER O ARG; R38 ES ARG O GLN; R39 ES GLY O ARG; R40 ES ALA O SER; R42 ES PHE O ALA; R43 ES ASN O ARG; R44 ES UN AMINOACIDO NATURAL, TAL COMO LEU O VAL. SE PUEDEN SUPRIMIR SECUENCIAS DE C-TERMINAL DE 1-15 RESIDUOS, QUE COMIENZAN EN R44 Y CONTINUAN HASTA R29. ESTOS PEPTIDOS, ASI COMO SUS SALES NO TOXICAS, TAMBIEN SE PUEDEN USAR EN DIAGNOSTICO.
ES89307089T 1988-07-22 1989-07-13 Compuestos analogos ciclicos a grf. Expired - Lifetime ES2055792T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/223,277 US5043322A (en) 1988-07-22 1988-07-22 Cyclic GRF analogs

Publications (1)

Publication Number Publication Date
ES2055792T3 true ES2055792T3 (es) 1994-09-01

Family

ID=22835815

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89307089T Expired - Lifetime ES2055792T3 (es) 1988-07-22 1989-07-13 Compuestos analogos ciclicos a grf.

Country Status (13)

Country Link
US (1) US5043322A (es)
EP (1) EP0352014B1 (es)
JP (1) JP2739910B2 (es)
KR (1) KR0138907B1 (es)
AT (1) ATE103609T1 (es)
DE (1) DE68914205T2 (es)
DK (1) DK355889A (es)
ES (1) ES2055792T3 (es)
FI (1) FI91074C (es)
IE (1) IE892378L (es)
IL (1) IL90766A0 (es)
NO (1) NO892970L (es)
ZA (1) ZA895050B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018531A1 (en) * 1991-04-09 1992-10-29 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5262519A (en) * 1991-05-15 1993-11-16 The Salk Institute For Biological Studies GRF analogs XI
US5371070A (en) * 1992-11-09 1994-12-06 The Salk Institute For Biological Studies Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
WO2000078956A1 (en) * 1999-06-23 2000-12-28 The Wistar Institute Of Anatomy And Biology Novel pyrrhocoricin-derived peptides, and methods of use thereof
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
AU2008232709C1 (en) 2007-03-28 2015-01-15 President And Fellows Of Harvard College Stitched polypeptides
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
CA2822442C (en) 2010-12-22 2021-03-16 The Salk Institute For Biological Studies Cyclic crf antagonist peptides
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
AU2013337388B2 (en) 2012-11-01 2018-08-02 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
WO2016049359A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
MX2017011834A (es) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595676A (en) * 1983-04-26 1986-06-17 The Salk Institute For Biological Studies Rat hypothalamic GRF
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
US4626523A (en) * 1983-09-13 1986-12-02 The Salk Institute For Biological Studies GRF analogs II
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
US4734399A (en) * 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
IL84758A (en) * 1987-01-13 1992-03-29 Salk Inst For Biological Studi Peptides stimulating the release of pituitary growth hormone in fish and amphibians,and pharmaceutical compositions containing them
US4784987A (en) * 1987-01-13 1988-11-15 The Salk Institute For Biological Studies GRF analogs VI
ES2054754T3 (es) * 1987-09-18 1994-08-16 Hoffmann La Roche Analogos ciclicos del grf.

Also Published As

Publication number Publication date
FI91074B (fi) 1994-01-31
FI893532A (fi) 1990-01-23
DK355889A (da) 1990-01-23
DE68914205T2 (de) 1994-07-07
EP0352014B1 (en) 1994-03-30
NO892970D0 (no) 1989-07-20
FI91074C (fi) 1994-05-10
KR0138907B1 (ko) 1998-04-30
JPH0269499A (ja) 1990-03-08
NO892970L (no) 1990-01-23
US5043322A (en) 1991-08-27
IE892378L (en) 1990-01-22
DK355889D0 (da) 1989-07-18
EP0352014A2 (en) 1990-01-24
JP2739910B2 (ja) 1998-04-15
IL90766A0 (en) 1990-01-18
KR910002900A (ko) 1991-02-26
DE68914205D1 (de) 1994-05-05
ATE103609T1 (de) 1994-04-15
EP0352014A3 (en) 1991-07-03
ZA895050B (en) 1990-04-25
FI893532A0 (fi) 1989-07-21

Similar Documents

Publication Publication Date Title
EG17394A (en) G r f analogs iv
ES8600217A1 (es) Un procedimiento para producir peptidos que influyen en la funcion de la glandula pituitaria
ES2055792T3 (es) Compuestos analogos ciclicos a grf.
ES2085350T3 (es) Analogos viia del factor de liberacion de la hormona de crecimiento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 352014

Country of ref document: ES